Abstract
Interim Report on the Safety and Efficacy of Longer-term Treatment With Nusinersen in Later-onset Spinal Muscular Atrophy (SMA): Results From the SHINE Study (P1.6-063)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have